<i>In silico</i> screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors.

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors.

Gurung, Arun Bahadur; Ali, Mohammad Ajmal; Lee, Joongku; Abul Farah, Mohammad; Al-Anazi, Khalid Mashay.

Afiliação

Gurung AB; Department of Basic Sciences and Social Sciences, North-Eastern Hill University, Shillong 793022, Meghalaya, India.
Ali MA; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Lee J; Department of Environment and Forest Resources, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
Abul Farah M; Genetics Laboratory, Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Al-Anazi KM; Genetics Laboratory, Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.

Saudi J Biol Sci ; 27(10): 2674-2682, 2020 Oct.

Article em En | MEDLINE | ID: mdl-32837219